TY  - RPRT
TI  - A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
AU  - Paul A Nausieda
AU  - Ronald F Pfeiffer
AU  - Michele Tagliati
AU  - Kathleen V Kastenholz
AU  - Carole DeRoche
AU  - John T Slevin
PY  - 2005
DO  - 10.1016/j.clinthera.2005.01.004
UR  - https://pubmed.ncbi.nlm.nih.gov/15763606/
ID  - 15763606
ER  -